I agree that this site is using cookies. You can find further informations here.
X
Byth, Kate
34  results:
Search for persons X
?
1

The Specific NLRP3 Antagonist IFM-514 Decreases Fibrosis an..:

Torres, Sandra ; Brol, Maximilian J ; Magdaleno, Fernando...
Frontiers in Molecular Biosciences.  8 (2021)  - p. , 2021
Link: https://doi.org/10.3389/..
 
?
2

Development of a Novel B-Cell Lymphoma 6 (BCL6) PROTAC To P..:

McCoull, William ; Cheung, Tony ; Anderson, Erica...
ACS Chemical Biology.  13 (2018)  11 - p. 3131-3141 , 2018
Link: https://doi.org/10.1021/..
 
?
3

Discovery of Pyrazolo[1,5-a]pyrimidine B-Cell Lymphoma 6 (B..:

McCoull, William ; Abrams, Roman D. ; Anderson, Erica...
Journal of Medicinal Chemistry.  60 (2017)  10 - p. 4386-4402 , 2017
Link: https://doi.org/10.1021/..
 
?
4

Correction to Discovery of Pyrazolo[1,5-a]pyrimidine B-Cell..:

McCoull, William ; Abrams, Roman D. ; Anderson, Erica...
Journal of Medicinal Chemistry.  60 (2017)  14 - p. 6459-6459 , 2017
Link: https://doi.org/10.1021/..
 
?
5

Comparative analysis of primary versus relapse/refractory D..:

Greenawalt, Danielle M. ; Liang, Winnie S. ; Saif, Sakina...
Oncotarget.  8 (2017)  59 - p. 99237-99244 , 2017
Link: https://doi.org/10.18632..
 
?
6

Identification and Optimization of Benzimidazole Sulfonamid..:

Hennessy, Edward J. ; Oza, Vibha ; Adam, Ammar...
Journal of Medicinal Chemistry.  58 (2015)  17 - p. 7057-7075 , 2015
Link: https://doi.org/10.1021/..
 
?
7

Discovery of heterocyclic sulfonamides as sphingosine 1-pho..:

Hennessy, Edward J. ; Grewal, Gurmit ; Byth, Kate...
Bioorganic & Medicinal Chemistry Letters.  25 (2015)  10 - p. 2041-2045 , 2015
Link: https://doi.org/10.1016/..
 
?
8

Towards the next generation of dual Bcl-2/Bcl-xL inhibitors:

Varnes, Jeffrey G. ; Gero, Thomas ; Huang, Shan...
Bioorganic & Medicinal Chemistry Letters.  24 (2014)  14 - p. 3026-3033 , 2014
Link: https://doi.org/10.1016/..
 
?
9

A phase I pharmacodynamic study of the effects of the cycli..:

Camidge, D. Ross ; Pemberton, Mike ; Growcott, Jim...
Cancer Chemotherapy and Pharmacology.  60 (2006)  4 - p. 479-488 , 2006
Link: https://doi.org/10.1007/..
 
?
10

Novel approaches in oncology at AstraZeneca:

Wheeler, Catherine ; Stephens, Trevor ; Byth, Kate...
European Journal of Cancer Supplements.  1 (2003)  8 - p. 3-8 , 2003
Link: https://doi.org/10.1016/..
 
?
11

Pre-clinical pharmacology of AZD3965, a selective inhibitor..:

Curtis, Nicola J. ; Mooney, Lorraine ; Hopcroft, Lorna...
Oncotarget.  8 (2017)  41 - p. 69219-69236 , 2017
Link: https://doi.org/10.18632..
 
?
12

Differential regulation of mTOR signaling determines sensit..:

Ezell, Scott A. ; Wang, Suping ; Bihani, Teeru...
Oncotarget.  7 (2016)  8 - p. 9163-9174 , 2016
Link: https://doi.org/10.18632..
 
?
13

Synergistic induction of apoptosis by combination of BTK an..:

Ezell, Scott A. ; Mayo, Michele ; Bihani, Teeru...
Oncotarget.  5 (2014)  13 - p. 4990-5001 , 2014
Link: https://doi.org/10.18632..
 
?
14

Mechanism and In Vitro Pharmacology of TAK1 Inhibition by (..:

Wu, Jiaquan ; Powell, Francoise ; Larsen, Nicholas A....
ACS Chemical Biology.  8 (2013)  3 - p. 643-650 , 2013
Link: https://doi.org/10.1021/..
 
?
15

Imidazoles: SAR and development of a potent class of cyclin..:

Anderson, Malcolm ; Andrews, David M. ; Barker, Andy J....
Bioorganic & Medicinal Chemistry Letters.  18 (2008)  20 - p. 5487-5492 , 2008
Link: https://doi.org/10.1016/..
 
1-15